0001104659-21-020197.txt : 20210211 0001104659-21-020197.hdr.sgml : 20210211 20210211063724 ACCESSION NUMBER: 0001104659-21-020197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210210 FILED AS OF DATE: 20210211 DATE AS OF CHANGE: 20210211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beebe Katherine CENTRAL INDEX KEY: 0001768867 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 21616597 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD, SUITE 505 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm216217-1_4.xml OWNERSHIP DOCUMENT X0306 4 2021-02-10 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001768867 Beebe Katherine 400 OYSTER POINT BLVD, SUITE 505 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and COO Option to Purchase Common Stock 4.02 2021-02-10 4 A 0 150000 0 A 2031-02-10 Common Stock 150000 150000 D The options vest as to 75,000 shares on August 10, 2021 with the balance to vest in equal monthly installments over the 18 months thereafter. /S/ Kate Beebe Devarney 2021-02-10